Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party.
Santoro N, Mooyaart JE, Devillier R, Koc Y, Vydra J, Castagna L, Gülbas Z, Martin JD, Araujo MC, Kulagin A, Arat M, Arroyo CH, Martelli MP, Di Ianni M, Hoogenboom JD, de Wreede LC, Ruggeri A, Chabannon C. Santoro N, et al. Among authors: vydra j. Bone Marrow Transplant. 2023 Jan;58(1):119-120. doi: 10.1038/s41409-022-01855-8. Bone Marrow Transplant. 2023. PMID: 36517566 No abstract available.
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis.
McLornan D, Eikema DJ, Czerw T, Kröger N, Koster L, Reinhardt HC, Angelucci E, Robin M, Bornhäuser M, Passweg J, Clark A, Vydra J, Blau IE, Niittyvuopio R, Platzbecker U, Cornelissen JJ, Chevallier P, Srour M, Stamatovic D, Martinez-Lopez J, de Wreede L, Hayden P, Hernández-Boluda JC, Yakoub-Agha I. McLornan D, et al. Among authors: vydra j. Bone Marrow Transplant. 2021 Sep;56(9):2160-2172. doi: 10.1038/s41409-021-01305-x. Epub 2021 Apr 28. Bone Marrow Transplant. 2021. PMID: 33911203
Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age.
Baron F, Labopin M, Tischer J, Ciceri F, Raiola AM, Blaise D, Sica S, Vydra J, Fanin R, Stölzel F, Busca A, Diez-Martin JL, Koc Y, Nagler A, Mohty M. Baron F, et al. Among authors: vydra j. Am J Hematol. 2022 Aug;97(8):1065-1074. doi: 10.1002/ajh.26627. Epub 2022 Jun 24. Am J Hematol. 2022. PMID: 35696192 Free article.
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Ruggeri A, Galimard JE, Labopin M, Rafii H, Blaise D, Ciceri F, Diez-Martin JL, Cornelissen J, Chevallier P, Sanchez-Guijo F, Nicholson E, Castagna L, Forcade E, Kuball J, Rovira M, Koc Y, Pavlu J, Gulbas Z, Vydra J, Baron F, Sanz J, Spyridonidis A, Savani B, Gluckman E, Nagler A, Mohty M. Ruggeri A, et al. Among authors: vydra j. Transplant Cell Ther. 2022 Oct;28(10):710.e1-710.e10. doi: 10.1016/j.jtct.2022.07.006. Epub 2022 Jul 11. Transplant Cell Ther. 2022. PMID: 35830930 Free article.
Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.
Baron F, Labopin M, Tischer J, Ciceri F, Raiola AM, Blaise D, Sica S, Vydra J, Fanin R, Diez-Martin JL, Bulabois CE, Stölzel F, Busca A, Jindra P, Koc Y, Chevallier P, Forcade E, Rösler W, Passweg J, Kulagin A, Carella AM, Simand C, Bazarbachi A, Pioltelli P, Nagler A, Mohty M. Baron F, et al. Among authors: vydra j. Bone Marrow Transplant. 2022 Nov;57(11):1657-1663. doi: 10.1038/s41409-022-01781-9. Epub 2022 Aug 17. Bone Marrow Transplant. 2022. PMID: 35978005 Free article.
Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT.
Spyridonidis A, Labopin M, Brissot E, Moiseev I, Cornelissen J, Choi G, Ciceri F, Vydra J, Reményi P, Rovira M, Meijer E, Labussière-Wallet H, Blaise D, van Gorkom G, Kröger N, Koc Y, Giebel S, Bazarbachi A, Savani B, Nagler A, Mohty M. Spyridonidis A, et al. Among authors: vydra j. Bone Marrow Transplant. 2022 Dec;57(12):1774-1780. doi: 10.1038/s41409-022-01816-1. Epub 2022 Sep 7. Bone Marrow Transplant. 2022. PMID: 36071114
Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMT.
Nagler A, Labopin M, Arat M, Reményi P, Koc Y, Blaise D, Angelucci E, Vydra J, Kulagin A, Socié G, Rovira M, Sica S, Aljurf M, Gülbas Z, Kröger N, Brissot E, Peric Z, Giebel S, Ciceri F, Mohty M. Nagler A, et al. Among authors: vydra j. Cancer. 2022 Nov 15;128(22):3959-3968. doi: 10.1002/cncr.34452. Epub 2022 Sep 15. Cancer. 2022. PMID: 36110063 Free article.
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party.
Santoro N, Mooyaart JE, Devillier R, Koc Y, Vydra J, Castagna L, Gülbas Z, Martin JD, Araujo MC, Kulagin A, Arat M, Arroyo CH, Martelli MP, Di Ianni M, Hoogenboom JD, de Wreede LC, Ruggeri A, Chabannon C. Santoro N, et al. Among authors: vydra j. Bone Marrow Transplant. 2023 Jan;58(1):54-60. doi: 10.1038/s41409-022-01839-8. Epub 2022 Oct 10. Bone Marrow Transplant. 2023. PMID: 36216975
Correction: Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.
Baron F, Labopin M, Tischer J, Ciceri F, Raiola AM, Blaise D, Sica S, Vydra J, Fanin R, Diez-Martin JL, Bulabois CE, Stölzel F, Busca A, Jindra P, Koc Y, Chevallier P, Forcade E, Rösler W, Passweg J, Kulagin A, Carella AM, Simand C, Bazarbachi A, Pioltelli P, Nagler A, Mohty M. Baron F, et al. Among authors: vydra j. Bone Marrow Transplant. 2022 Nov;57(11):1747. doi: 10.1038/s41409-022-01856-7. Bone Marrow Transplant. 2022. PMID: 36280760 No abstract available.
Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A, Labopin M, Swoboda R, Kulagin A, Labussière-Wallet H, Rovira M, Blaise D, Vydra J, Yakoub-Agha I, Choi G, Reményi P, Koc Y, Sanz J, Ciceri F, Mohty M. Nagler A, et al. Among authors: vydra j. Bone Marrow Transplant. 2023 May;58(5):552-557. doi: 10.1038/s41409-023-01940-6. Epub 2023 Feb 23. Bone Marrow Transplant. 2023. PMID: 36823454
60 results